Daniel C Bowers Selected Research

Daniel C Bowers Research Topics

Disease

29	Neoplasms (Cancer) 04/2024 - 08/2003
12	Glioma (Gliomas) 03/2024 - 02/2002
9	Medulloblastoma 01/2021 - 01/2004
6	Brain Neoplasms (Brain Tumor) 11/2020 - 11/2006
4	Stroke (Strokes) 11/2023 - 02/2002
4	Ependymoma 01/2023 - 07/2011
3	Central Nervous System Neoplasms 01/2021 - 07/2013
3	Disease Progression 01/2020 - 08/2002
3	Neutropenia 01/2020 - 01/2005
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2019 - 01/2010
2	Hemorrhage 10/2022 - 01/2020
2	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 10/2022 - 02/2006
2	Sarcoma (Soft Tissue Sarcoma) 10/2022 - 11/2017
2	Primitive Neuroectodermal Tumors (PNET) 10/2022 - 01/2012
2	Neuroblastoma 10/2022 - 01/2004
2	Microsatellite Instability 01/2021 - 11/2017
2	Turcot syndrome 01/2021 - 01/2019
2	Meningioma (Meningiomas) 04/2020 - 05/2017
2	Diffuse Intrinsic Pontine Glioma 01/2020 - 10/2018
2	Pinealoma (Pineoblastoma) 01/2020 - 01/2020
2	Astrocytoma (Pilocytic Astrocytoma) 05/2013 - 05/2003
2	Leukemia 05/2013 - 11/2006
2	Oligodendroglioma 05/2003 - 08/2002
1	Neurologic Manifestations (Neurological Manifestations) 11/2023
1	Migraine Disorders (Migraine) 11/2023
1	Headache (Headaches) 11/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Necrosis 03/2021
1	Choroid Plexus Carcinoma 01/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Fatigue 01/2020
1	Thrombocytopenia 3 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Leukoencephalopathies 12/2019
1	Avian Reticuloendotheliosis 10/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2013
1	Plexiform Neurofibroma 12/2012
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 12/2012
1	Pain (Aches) 11/2012
1	Obesity 11/2012
1	Back Pain (Backache) 11/2012

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2011
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2005 - 07/2002
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2021 - 11/2017
2	dipinacoline glutamateIBA 01/2020 - 10/2018
2	Growth Hormone (Somatotropin)IBA 01/2019 - 12/2009
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 01/2017
2	Histones (Histone)IBA 05/2014 - 07/2011
2	Sirolimus (Rapamycin)FDA Link 07/2011 - 06/2010
2	Temozolomide (Temodar)FDA LinkGeneric 02/2006 - 01/2005
2	Anticonvulsants (Antiepileptic Drugs)IBA 05/2003 - 07/2002
2	EnzymesIBA 05/2003 - 07/2002
1	Methotrexate (Mexate)FDA LinkGeneric 11/2023
1	Everolimus FDA Link 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022
1	Tuberculin (PPD)IBA 01/2022
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2021
1	ProteomeIBA 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	CarcinogensIBA 11/2017
1	MutagensIBA 11/2017
1	HhAntag691IBA 09/2017
1	trametinibIBA 01/2017
1	dabrafenibIBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	Etoposide (VP 16)FDA LinkGeneric 01/2016
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 05/2014
1	cyclo(Arg-Pro) (CI 4)IBA 07/2013
1	Dihydrotachysterol (AT 10)IBA 07/2013
1	Transcription Factors (Transcription Factor)IBA 05/2013
1	Proto-Oncogene Proteins B-rafIBA 05/2013
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2013
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2013
1	Imatinib Mesylate (Gleevec)FDA Link 12/2012
1	Transaminases (Aminotransferases)IBA 12/2012
1	ChemokinesIBA 08/2012
1	Protein CIBA 08/2012
1	Interleukin-5 (Interleukin 5)IBA 08/2012
1	CytokinesIBA 08/2012

Therapy/Procedure

27	Therapeutics 04/2024 - 07/2002
22	Radiotherapy 11/2023 - 02/2002
9	Drug Therapy (Chemotherapy) 10/2022 - 01/2004
2	Immunotherapy 01/2022 - 01/2021
2	Aftercare (After-Treatment) 12/2009 - 05/2009
1	Combined Modality Therapy 12/2022
1	Cranial Irradiation 10/2022
1	Re-Irradiation 03/2021
1	Craniospinal Irradiation 01/2020
1	Consolidation Chemotherapy 10/2019
1	Maintenance Chemotherapy 10/2019
1	Molecular Targeted Therapy 01/2017
1	Chemoradiotherapy 12/2012